— Know what they know.
Not Investment Advice
Also trades as: 0KSX.L (LSE) · $vol 0M

DGX NYSE

Quest Diagnostics Incorporated
1W: +2.3% 1M: +2.5% 3M: +3.1% YTD: +40.2% 1Y: +33.1% 3Y: +104.0% 5Y: +80.3%
$242.56
-0.39 (-0.16%)
Pre-Market: $243.97 (+1.41, +0.58%)
Weekly Expected Move ±2.8%
$228 $235 $242 $249 $255
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 65 · $26.8B mcap · 110M float · 0.932% daily turnover · Short 66% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 19.0% of company value Bonds: $173.4M held by 208 funds, 54 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.08 (down 99%), Quest Diagnostics Incorporated would be worth roughly what it owes.
Total debt $6.29B against a stock market value of $26.77B.
Distance to default 10.60 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $3.24B (short-term plus half of long-term), stock volatility 23.6%; Altman Z'' 4.04. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$16.2B +0.4% ▲
5Y CAGR: +3.0%
Total Liabilities
$8.9B -3.4% ▼
5Y CAGR: +4.6%
Shareholders Equity
$7.2B +5.8% ▲
5Y CAGR: +1.2%
Cash & Investments
$420M -23.5% ▼
5Y CAGR: -18.4%
Total Debt
$6.9B -2.4% ▼
5Y CAGR: +7.6%
Net Debt
$6.5B -0.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$872M$315M$686M$549M$420M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$872M$315M$686M$549M$420M
Net Receivables$1.4B$1.2B$1.2B$1.3B$1.4B
Inventory$208M$192M$190M$188M$189M
Other Current Assets$0$196M$286M$351M$361M
Total Current Assets$2.7B$1.9B$2.4B$2.4B$2.4B
Property, Plant & Equip.$2.3B$2.4B$2.4B$2.8B$2.9B
Goodwill & Intangibles$8.3B$8.3B$8.9B$10.6B$10.6B
Long-Term Investments$141M$132M$135M$123M$136M
Other Non-Current Assets$163M$144M$198M$255M$270M
Total Non-Current Assets$10.9B$10.9B$11.7B$13.8B$13.8B
Total Assets$13.6B$12.8B$14.0B$16.2B$16.2B
— Liabilities —
Accounts Payable$357M$324M$378M$287M$1.6B
Short-Term Debt$269M$247M$585M$937M$678M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$599M$550M$471M$466M$0
Total Current Liabilities$1.8B$1.6B$1.8B$2.2B$2.3B
Long-Term Debt$4.0B$4.0B$4.4B$5.6B$5.7B
Other Non-Current Liab.$502M$517M$606M$688M$420M
Total Non-Current Liabilities$5.3B$5.3B$5.8B$7.1B$6.7B
Total Liabilities$7.0B$6.8B$7.6B$9.3B$8.9B
— Equity —
Common Stock$2M$2M$2M$2M$2M
Retained Earnings$7.6B$8.3B$8.8B$9.4B$10.0B
Accumulated OCI-$14M-$21M-$14M-$88M-$27M
Total Stockholders Equity$6.4B$5.9B$6.3B$6.8B$7.2B
Total Liabilities & Equity$13.6B$12.8B$14.0B$16.2B$16.2B
— Key Metrics —
Total Debt$4.8B$4.7B$5.5B$7.1B$6.9B
Net Debt$3.9B$4.4B$4.8B$6.5B$6.5B
Total Investments$141M$132M$135M$123M$136M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms